Losses from fluctuations in the prices of securities held
First written in FY2017-Q1. 14 of 29 entries say "Materialised", first in FY2019-Q3. Latest entry: 2026-07-28.
The whole theme swung hardest in 2026: 38 of 81 companies on the "Worse" side.
- 2026-07-28MitigatedResults
「その他有価証券（a） 1,144 98,421 97,277 △ 9,198 56,545 65,744」
その他有価証券の評価損益が2026年３月末のマイナス4,701百万円からプラス1,144百万円へ改善した。 - FY2026Market risk declined while impairment losses on unlisted shares increasedAnnual report
「At the end of the current consolidated fiscal year, the market risk exposure of the Bank Group, measured as the estimated decrease in economic value, totaled ¥60,708 million, compared with ¥68,757 million at the end of the previous consolidated fiscal year. During the current consolidated fiscal year, impairment losses of ¥1,463 million were recognized on unlisted shares.」
While market risk exposure decreased from the end of the previous fiscal year, ¥1,463 million in impairment losses was recognized on unlisted shares, indicating divergent trends in market-related indicators and losses. - FY2024-Q3MitigatedAnnual report
「No impairment losses were recorded in the previous consolidated fiscal year or the current third-quarter consolidated cumulative period.」
There were no impairment losses on securities in the previous fiscal year or the first 3 quarters of the current fiscal year. Other securities valuation difference gains/losses improved from negative ¥6,537 million at the end of the previous fiscal year to ¥6,104 million. - FY2024-Q2MaterialisedAnnual report
「Other securities valuation difference gains/losses △6,537 △13,085」
Other securities valuation difference gains/losses declined from negative ¥6,537 million at the end of the previous fiscal year to negative ¥13,085 million, and the increase in unrealized losses affected net assets. There were no impairment losses on securities in the interim period of the current consolidated fiscal year. - FY2024-Q1MitigatedAnnual report
「No impairment losses were recorded during the previous consolidated fiscal year or the first-quarter consolidated accounting period.」
There were no impairment losses on securities in the previous fiscal year or the first quarter of the current fiscal year, and no materialization of losses from price fluctuations was identified for the current quarter. Other securities valuation difference gains/losses also improved from negative to positive compared with the end of the previous fiscal year. - FY2023-Q3MaterialisedAnnual report
「In addition, net assets decreased by ¥32,629 million from the end of the previous consolidated fiscal year to ¥253,844 million, mainly because other securities valuation difference gains/losses declined as unrealized losses on bonds, investment trusts and other securities increased.」
As unrealized losses on bonds, investment trusts and other securities increased, other securities valuation difference gains/losses declined from ¥15,121 million to negative ¥24,603 million, and net assets decreased by ¥32,629 million from the end of the previous fiscal year. Meanwhile, there were no impairment losses on securities in the first 3 quarters of the current fiscal year. - FY2023-Q2MaterialisedAnnual report
「In addition, net assets decreased by ¥28,154 million from the end of the previous consolidated fiscal year to ¥258,319 million, mainly because other securities valuation difference gains/losses declined as unrealized losses on foreign bonds, investment trusts and other securities increased.」
As unrealized losses on foreign bonds, investment trusts and other securities increased, other securities valuation difference gains/losses declined from ¥15,121 million to negative ¥20,446 million, and net assets decreased by ¥28,154 million from the end of the previous fiscal year. The impact of losses from fluctuations in the prices of securities held has materialized in the results. - FY2023-Q1MaterialisedAnnual report
「Impairment losses for the first quarter of the current consolidated fiscal year totaled ¥23 million, all on shares.」
As a loss related to fluctuations in the prices of securities held, ¥23 million in impairment losses on shares was recognized in the first quarter of the current fiscal year. - FY2022Market risk declined while impairment losses on shares increasedAnnual report
「At the end of the current consolidated fiscal year, the market risk exposure of the Bank Group, measured as the estimated decrease in economic value, totaled ¥56,464 million, compared with ¥58,770 million at the end of the previous consolidated fiscal year.」
While market risk exposure decreased from the end of the previous fiscal year, impairment losses on shares increased from ¥33 million to ¥143 million, indicating divergent trends in market-risk indicators. - FY2022-Q3MaterialisedAnnual report
「Impairment losses for the first 3 quarters of the current consolidated fiscal year totaled ¥110 million, all on shares.」
As a loss related to fluctuations in the prices of securities held, ¥110 million in impairment losses on shares was recognized in the first 3 quarters of the current consolidated fiscal year, up from ¥33 million in the previous fiscal year. - FY2022-Q2MaterialisedAnnual report
「Impairment losses for the interim period of the current consolidated fiscal year totaled ¥92 million, all on shares.」
As a loss related to fluctuations in the prices of securities held, ¥92 million in impairment losses on shares was recognized in the interim period of the current consolidated fiscal year. - FY2022-Q1MaterialisedAnnual report
「Impairment losses for the first quarter of the current consolidated fiscal year totaled ¥96 million, all on shares.」
As a loss related to fluctuations in the prices of securities held, ¥96 million in impairment losses on shares was recognized in the first quarter of the current fiscal year. - FY2021WorsenedAnnual report
「At the end of the current consolidated fiscal year, the market risk exposure of the Bank Group, measured as the estimated decrease in economic value, totaled ¥58,770 million, compared with ¥52,531 million at the end of the previous consolidated fiscal year.」
The estimated market risk exposure increased from ¥52,531 million at the end of the previous fiscal year to ¥58,770 million. - FY2021-Q3MaterialisedAnnual report
「Impairment losses for the first 3 quarters of the current consolidated fiscal year totaled ¥114 million, all on shares.」
As a loss related to fluctuations in the prices of securities held, ¥114 million in impairment losses on shares was recognized in the first 3 quarters of the current consolidated fiscal year. - FY2021-Q2MaterialisedAnnual report
「Impairment losses for the interim period of the current consolidated fiscal year totaled ¥44 million, all on shares.」
As a loss related to fluctuations in the prices of securities held, ¥44 million in impairment losses on shares was recognized in the interim period of the current consolidated fiscal year. - FY2021-Q1MaterialisedAnnual report
「Impairment losses for the first quarter of the current consolidated fiscal year totaled ¥1 million, all on shares.」
As a loss related to fluctuations in the prices of securities held, ¥1 million in impairment losses on shares was recognized in the first quarter of the current fiscal year. - FY2020-Q3MaterialisedAnnual report
「Impairment losses for the first 3 quarters of the current consolidated fiscal year totaled ¥286 million, all on shares.」
Regarding losses from fluctuations in the prices of securities held, ¥286 million in impairment losses on shares was recognized in the first 3 quarters of the current consolidated fiscal year. - FY2020-Q2MaterialisedAnnual report
「Impairment losses for the interim period of the current consolidated fiscal year totaled ¥330 million, all on shares.」
Regarding losses from fluctuations in the prices of securities held, ¥330 million in impairment losses on shares was recognized in the interim period of the current consolidated fiscal year. - FY2020-Q1MaterialisedAnnual report
「Impairment losses for the first quarter of the current consolidated fiscal year totaled ¥245 million, all on shares.」
Following ¥335 million in impairment losses in the previous consolidated fiscal year, ¥245 million in impairment losses on shares was recognized in the first quarter of the current fiscal year. - FY2019-Q3MaterialisedAnnual report
「Impairment losses for the first 3 quarters of the current consolidated fiscal year totaled ¥252 million, all on shares.」
While there were no impairment losses in the previous consolidated fiscal year, ¥252 million in impairment losses on shares was recognized in the first 3 quarters of the current consolidated fiscal year. Losses from fluctuations in the prices of securities held have materialized. - FY2019-Q2RestatedAnnual report
「There were no impairment losses in the previous consolidated fiscal year or the interim period of the current consolidated fiscal year.」
It continues to disclose the risk of losses from fluctuations in the prices of securities held and states that there were no impairment losses in the previous fiscal year or the interim period of the current consolidated fiscal year. - FY2019-Q1RestatedAnnual report
「There were no impairment losses in the previous consolidated fiscal year or the first quarter of the current consolidated fiscal year.」
It continues to disclose the risk of losses from fluctuations in the prices of securities held, and there were no impairment losses on securities in the previous fiscal year or the first quarter of the current fiscal year. - FY2018MitigatedAnnual report
「At the end of the current consolidated fiscal year, the market risk exposure of the Bank Group, measured as the estimated decrease in economic value, totaled ¥56,285 million, compared with ¥59,428 million at the end of the previous consolidated fiscal year.」
The estimated market risk exposure decreased from ¥59,428 million at the end of the previous fiscal year to ¥56,285 million. - FY2018-Q3RestatedAnnual report
「No impairment losses were recorded in the previous consolidated fiscal year or the current third-quarter consolidated cumulative period.」
It continues to disclose the risk of losses from fluctuations in the prices of securities held. There were no impairment losses on securities in the first 3 quarters of the current consolidated fiscal year. - FY2018-Q2RestatedAnnual report
「In addition, as domestic and overseas economic and market conditions change, fluctuations in the prices of securities held, including shares, may result in losses. There were no impairment losses in the previous consolidated fiscal year. There were no impairment losses in the interim period of the current consolidated fiscal year.」
It continues to disclose the risk of losses from fluctuations in the prices of securities held. There were no impairment losses in the interim period of the current consolidated fiscal year. - FY2017WorsenedAnnual report
「At the end of the current consolidated fiscal year, the market risk exposure of the Bank Group, measured as the estimated decrease in economic value, totaled ¥59,428 million, compared with ¥53,513 million at the end of the previous consolidated fiscal year.」
The estimated market risk exposure increased from ¥53,513 million at the end of the previous fiscal year to ¥59,428 million. - FY2017-Q3RestatedAnnual report
「In addition, as domestic and overseas economic and market conditions change, fluctuations in the prices of securities held, including shares, may result in losses.」
The risk of losses from fluctuations in the prices of securities held continues to be disclosed. There were no impairment losses in the first 3 quarters of the current consolidated fiscal year. - FY2017-Q2RestatedAnnual report
「In addition, as domestic and overseas economic and market conditions change, fluctuations in the prices of securities held, including shares, may result in losses. Impairment losses for the previous fiscal year totaled ¥158 million, all on shares. Impairment losses for the interim period of the current consolidated fiscal year totaled ¥36 million, all on shares.」
It continues to disclose the risk of losses from fluctuations in the prices of securities held and reports ¥36 million in impairment losses on shares for the interim period of the current consolidated fiscal year. - FY2017-Q1First statedAnnual report
「In addition, as domestic and overseas economic and market conditions change, fluctuations in the prices of securities held, including shares, may result in losses. Impairment losses for the previous fiscal year totaled ¥158 million, all on shares. Impairment losses for the first quarter of the current consolidated fiscal year totaled ¥109 million, all on shares.」
It identifies fluctuations in the prices of securities held as a source of losses and reports impairment losses of ¥109 million on shares for the first quarter of the current consolidated fiscal year.